BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 2214642)

  • 1. [Effect of therapeutic plasmapheresis on the system of hemostasis in patients with chronic glomerulonephritis].
    Savitskaia IV; Dorofeev SB; Tov NL; Barkagan LZ
    Klin Med (Mosk); 1990 Jun; 68(6):65-8. PubMed ID: 2214642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study of the blood coagulation and fibrinolysis systems in evaluating the activity of glomerulonephritis].
    Savitskaia IV; Tov NL; Movchan EA; Barkagan LZ; Sidorova LD
    Klin Med (Mosk); 1989 Feb; 67(2):49-53. PubMed ID: 2724886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the pro-thrombotic state in CAPD patients.
    Preloznik Zupan I; Sabovic M; Salobir B; Buturovic Ponikvar J
    Ren Fail; 2008; 30(6):597-602. PubMed ID: 18661409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Role of the hemostatic system in the progression of acute glomerulonephritis].
    Movchan EA; Tov NL; Loskutova SA; Chuprova AV
    Ter Arkh; 2001; 73(6):40-3. PubMed ID: 11521520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Vessel-platelet and coagulation components of hemostasis in patients with chronic tubulointerstitial nephritis].
    Suvorova TS; Tov NL; Movchan EA
    Ter Arkh; 2007; 79(6):56-60. PubMed ID: 17684969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The coagulating and anticoagulating blood systems and thrombocyte aggregation in healthy subjects and patients with ischemic heart disease at rest and under physical loading].
    Kovalenko VM; Shunkova EI; Gol'dberg GA; Karagaeva LG; Shlafer ID; Epifantseva NN
    Ter Arkh; 1991; 63(4):69-71. PubMed ID: 2068682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Functional status of the hemostatic and fibrinolytic systems in patients with clinical variants of chronic glomerulonephritis].
    Miagkov II; Nazar PS
    Ter Arkh; 1989; 61(11):123-6. PubMed ID: 2633374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The role of thrombocytic-vascular and coagulative hemostasis in the pathogenesis of the Raynaud's phenomenon].
    Slutsker GE; Promakhina EK
    Vestn Khir Im I I Grek; 1990 Apr; 144(4):40-3. PubMed ID: 2173227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The kallikrein-kinin, coagulation and fibrinolytic systems of the blood in patients with chronic glomerulonephritis and the hypertension syndrome].
    Nazar PS; Cherniavskaia GF
    Vrach Delo; 1989 Aug; (8):6-8. PubMed ID: 2588532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased platelet and coagulatory activity in peripheral atherosclerosis flow mediated platelet function is a sensitive and specific disease indicator.
    Reininger CB; Graf J; Reininger AJ; Spannagl M; Steckmeier B; Schweiberer L
    Int Angiol; 1996 Dec; 15(4):335-43. PubMed ID: 9127775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Thrombocyte function and fibrinogen degradation products in glomerulonephritis].
    Fazlyeva RM
    Klin Med (Mosk); 1978 Nov; 56(11):75-81. PubMed ID: 723202
    [No Abstract]   [Full Text] [Related]  

  • 12. [The effect of therapeutic plasmapheresis on the hemostatic system of patients with chronic glomerulonephritis and the nephrotic syndrome].
    Kolesnyk MO; Lapchyns'ka II; Dudar IO; Velychko MB
    Lik Sprava; 1993; (2-3):79-81. PubMed ID: 8191743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The mechanisms of intravascular blood coagulation in patients with systemic scleroderma].
    Diubanova GA; Sidorova LD; Barkagan LZ; Movchan EA; Valentik MF
    Ter Arkh; 1990; 62(5):63-6. PubMed ID: 2396220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Demonstration of platelet-derived microvesicles in blood from patients with activated coagulation and fibrinolysis using a filtration technique and western blotting.
    Holme PA; Solum NO; Brosstad F; Røger M; Abdelnoor M
    Thromb Haemost; 1994 Nov; 72(5):666-71. PubMed ID: 7900071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of factors influencing platelet aggregation in patients with chronic glomerulonephritis (CGN)].
    Zdrojewski Z; Raszeja-Specht A; Kustosz J; Skibowska A; Rutkowski B
    Przegl Lek; 1996; 53(5):434-8. PubMed ID: 8754409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Changes in general hemostasis in patients with diabetic retinopathy].
    Evgrafov VIu; Markova OA; Grishin VL; Efimov VS
    Vestn Oftalmol; 2004; 120(3):29-31. PubMed ID: 15216770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Various pathophysiological conditions seen in glomerulonephritis--hypercoagulative state, abnormal fibrinolysis and platelets in glomerulonephritis and the treatment].
    Koyama A; Kobayashi M; Yamaguchi N
    Nihon Rinsho; 1988 Jun; 46(6):1326-32. PubMed ID: 3418902
    [No Abstract]   [Full Text] [Related]  

  • 18. [Changes in blood coagulation in glomerulonephritis].
    Robeva R; Belovezhdov N; Genova V
    Vutr Boles; 1982; 21(6):1-7. PubMed ID: 6219496
    [No Abstract]   [Full Text] [Related]  

  • 19. [Disorders of hemostasis after polytrauma. On the extent of intrinsic fibrinolytic activity in the preclinical phase].
    Lampl L; Bock KH; Hartel W; Helm M; Tisch M; Seifried E
    Chirurg; 1992 Apr; 63(4):305-9. PubMed ID: 1597093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploration of intraglomerular phenomena by measurement of the level of fibrin degradation products in the renal vein blood.
    Conte J; Boneu B; Mignon-Conte ; Suc JM
    Perspect Nephrol Hypertens; 1973; 1 Pt 2(0):915-26. PubMed ID: 4807811
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.